Literature DB >> 14736447

Association between aldosterone synthase (CYP11B2) polymorphism and left ventricular mass in human essential hypertension.

Paola Stella1, Giada Bigatti, Laura Tizzoni, Cristina Barlassina, Chiara Lanzani, Giuseppe Bianchi, Daniele Cusi.   

Abstract

OBJECTIVES: The aim of our study was to evaluate the relationship between aldosterone synthase gene polymorphism and cardiac dimensions in essential hypertension.
BACKGROUND: Higher aldosterone synthase messenger ribonucleic acid levels in the human heart are accompanied by increased intracardiac aldosterone production, a phenomenon that is associated with cardiac fibrosis and hypertrophy. Recent evidence suggests that a polymorphism (-344C/T) in the promoter region of the aldosterone synthase gene is associated with increased constitutive aldosterone production.
METHOD: Relationships between M-mode echocardiographic cardiac dimensions and aldosterone synthase -344C/T polymorphism were studied in 210 never-treated, middle-aged patients (age 41.6 +/- 1.4 years) affected by mild to moderate essential hypertension. Among these patients, 48 had the genotype -C344C, 97 had -C344T, and 65 had -T344T. Patients in the three groups were similar in terms of age, gender, body mass index, and blood pressure.
RESULTS: Left ventricular (LV) mass and thickness were positively correlated with the number of T alleles: LV mass (CC, CT, and TT, respectively: 168 +/- 6.9, 179 +/- 5.2, and 193 +/- 6.9 g; p = 0.03), LV septal thickness (0.99 +/- 0.02, 1.03 +/- 0.02, and 11.08 +/- 0.03 cm, p = 0.04), PWT (0.93 +/- 0.03, 0.95 +/- 0.01, and 1.03 +/- 0.02 cm; p = 0.002), and relative wall thickness (38.3 +/- 1.2%, 38.8 +/- 0.8%, and 42.8 +/- 1.1%; p = 0.004). This trend was confirmed by linear regression, suggesting a "major gene" behavior for the T allele. Multiple regression analysis showed that this effect was independent of anthropometric and clinical factors, including adrenal aldosterone.
CONCLUSIONS: Our data suggest that -344C/T polymorphism affects LV mass and thickness in essential hypertension, independent of adrenal aldosterone. A role for intracardiac aldosterone synthesis is hypothesized.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14736447     DOI: 10.1016/j.jacc.2003.08.034

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  6 in total

Review 1.  Arterial Hypertension, Atrial Fibrillation, and Hyperaldosteronism: The Triple Trouble.

Authors:  Teresa M Seccia; Brasilina Caroccia; Gail K Adler; Giuseppe Maiolino; Maurizio Cesari; Gian Paolo Rossi
Journal:  Hypertension       Date:  2017-04       Impact factor: 10.190

Review 2.  Antihypertensive drugs and the heart.

Authors:  Joseph A Diamond; Robert A Phillips
Journal:  Curr Cardiol Rep       Date:  2004-11       Impact factor: 2.931

3.  Genetic epidemiology of left ventricular hypertrophy.

Authors:  Jonathan N Bella; Harald Hh Göring
Journal:  Am J Cardiovasc Dis       Date:  2012-10-25

4.  Interactions between CYP11B2 Promoter Methylation and Smoking Increase Risk of Essential Hypertension.

Authors:  Tianlun Gu; Shuqi Mao; Rui Fan; Fade Zhong; Fubao Zhu; Lingmei Hao; Lina Zhang; Fengying Yin
Journal:  Biomed Res Int       Date:  2016-12-19       Impact factor: 3.411

Review 5.  Why are mineralocorticoid receptor antagonists cardioprotective?

Authors:  Wenxia Chai; A H Jan Danser
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-10-31       Impact factor: 3.000

6.  Association of -344C/T polymorphism in the aldosterone synthase (CYP11B2) gene with cardiac and cerebrovascular events in Chinese patients with hypertension.

Authors:  Lili Wang; Zhi Zhang; Dongxia Liu; Kexin Yuan; Guohua Zhu; Xiaoyong Qi
Journal:  J Int Med Res       Date:  2020-09       Impact factor: 1.671

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.